American Society of Hematology--48th Annual Meeting and Exposition. Treatments for leukemia and lymphoma. 9-12 December 2006 Orlando, FL, USA.
Talmadge
James E
JE
University of Nebraska Medical Center, Laboratory of Transplantation Immunology Department of Pathology and Microbiology 985660, Omaha, NE 68198-5660, USA. jtalmadg@unmc.edu
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006405:Hematology / Q000639:trends*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053645:Interleukin-2 Receptor alpha Subunit / Q000037:antagonists & inhibitors; D007938:Leukemia / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy*; D011161:Porifera / Q000737:chemistry; D020123:Sirolimus / Q000627:therapeutic use; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000187:drug effects; D016559:Tacrolimus / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D053645:Interleukin-2 Receptor alpha Subunit; D020123:Sirolimus; D016559:Tacrolimus